Ambey Laboratories Limited IPO (Ambey Laboratories IPO) Detail.
IPO Details:
- IPO Date: July 4, 2024, to July 8, 2024
- Listing Date: July 11, 2024 (tentative)
- Face Value: ₹10 per share
- Price Band: ₹65 to ₹68 per share
- Lot Size: 2000 Shares
- Total Issue Size: 6,570,000 shares (₹44.68 Cr)
- Fresh Issue: 6,258,000 shares (₹42.55 Cr)
- Offer for Sale: 312,000 shares (₹2.12 Cr)
- Issue Type: Book Built Issue IPO
- Listing At: NSE SME
- Market Maker: Nikunj Stock Brokers
Shareholding:
- Pre Issue: 18,688,819 shares
- Post Issue: 25,258,819 shares
- Promoter Holding Pre Issue: 94.97%
- Promoter Holding Post Issue: 69.90%
Reservation:
- QIB: Not more than 50% of the Net Issue
- Retail: Not less than 35% of the Net Issue
- NII (HNI): Not less than 15% of the Net Issue
Anchor Investors:
- Bid Date: July 3, 2024
- Shares Offered: 1,872,000
- Anchor Portion Size: ₹12.73 Cr
- Lock-in Period:
- 50% shares: August 8, 2024
- Remaining shares: October 7, 2024
Timeline:
- Basis of Allotment: July 9, 2024
- Initiation of Refunds: July 10, 2024
- Credit of Shares to Demat: July 10, 2024
Lot Size Investment:
- Retail Investors: Minimum 1 lot (2000 shares, ₹136,000)
- HNI Investors: Minimum 2 lots (4000 shares, ₹272,000)
Financial Information (₹ Lakhs):
- Period Ended: January 31, 2024 / March 31, 2023 / March 31, 2022 / March 31, 2021
- Assets: 8,620.84 / 5,761.85 / 5,592.94 / 4,461.80
- Revenue: 10,043.69 / 10,743.47 / 8,511.19 / 8,241.54
- Profit After Tax: 607.73 / 456.93 / 357.47 / 1,033.67
- Net Worth: 3,431.34 / 2,363.60 / 1,906.67 / -786.39
- Reserves and Surplus: 1,562.46 / 588.66 / 131.73 / -1,275.74
- Total Borrowing: 2,005.44 / 1,365.22 / 1,804.86 / 3,292.98
Key Performance Indicators:
- Market Cap: ₹171.64 Cr
- ROE: 20.80%
- ROCE: 13.14%
- Debt/Equity: 0.58
- RoNW: 20.80%
- P/BV: 3.58
- PAT Margin: 6.01%
- EPS (Pre IPO): 2.44
- EPS (Post IPO): 2.89
- P/E (Pre IPO): 27.81
- P/E (Post IPO): 23.54
Use of Funds:
- Working Capital Requirements
- General Corporate Purposes
- Issue Related Expenses
Ambey Laboratories, established in 1985, specializes in agrochemical products for crop protection and has an ISO-certified manufacturing facility in Behror, Rajasthan. The company’s client base includes notable corporates like Aromatic Rasayan Private Limited and SC Formulator Co. Ltd.
About Ambey Laboratories Limited
Incorporation and History:
- Established: 1985
- Industry: Agrochemicals
- Location: Behror, Rajasthan, India
Operations: Ambey Laboratories specializes in manufacturing agrochemical products designed for crop protection. The company has nearly four decades of experience in the agrochemical sector, providing a range of chemicals that cater to the needs of the agricultural industry.
Products: Ambey Laboratories offers a diverse portfolio of agrochemical products, including but not limited to:
- 2,4-D Acid 98% TC
- 2,4-D Sodium 95% SP
- 2,4-D Amine 866 | 720 | 480g/l SL
- 2,4-D Ethyl Hexyl Ester 96% TC
- 2,4-D Ethyl Ester 96% TC
- Chlorpyriphos 97%TC / 20%EC / 50%EC
- Thiamethoxam 96%TC / 25%WG / 75%SG
- Pretilachlor 95%TC / 50%EC / 37%EW
- Metribuzin 97%TC / 70%WS
- Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC
- Metalaxyl 98%TC / 35%WS
These products are essential for various agricultural applications, including pest control and weed management.
Clients: Ambey Laboratories’ customer base includes large corporations such as:
- Aromatic Rasayan Private Limited
- JR Jindal Infraprojects Private Limited
- SC Formulator Co. Ltd
Certifications: The company’s manufacturing facility in Behror, Rajasthan, is certified with:
- ISO 9001:2015 by the Quality Research Organization
- ISO 14001:2015 by the United Accreditation Foundation
Workforce: As of October 31, 2023, Ambey Laboratories employs 220 people across various departments, ensuring efficient production and distribution of its agrochemical products.
Financial Performance (in ₹ Lakhs):
- Assets (January 31, 2024): 8,620.84
- Revenue (January 31, 2024): 10,043.69
- Profit After Tax (January 31, 2024): 607.73
- Net Worth (January 31, 2024): 3,431.34
- Reserves and Surplus (January 31, 2024): 1,562.46
- Total Borrowing (January 31, 2024): 2,005.44
Key Performance Indicators:
- Market Capitalization: ₹171.64 Cr
- Return on Equity (ROE): 20.80%
- Return on Capital Employed (ROCE): 13.14%
- Debt to Equity Ratio: 0.58
- Return on Net Worth (RoNW): 20.80%
- Price to Book Value (P/BV): 3.58
- Profit After Tax (PAT) Margin: 6.01%
Promoters:
- Archit Gupta
- Arpit Gupta
- Sarina Gupta
- Rishita Gupta
About Ambey Laboratories Limited
Incorporation and History:
- Established: 1985
- Industry: Agrochemicals
- Location: Behror, Rajasthan, India
Operations: Ambey Laboratories specializes in manufacturing agrochemical products designed for crop protection. The company has nearly four decades of experience in the agrochemical sector, providing a range of chemicals that cater to the needs of the agricultural industry.
Products: Ambey Laboratories offers a diverse portfolio of agrochemical products, including but not limited to:
- 2,4-D Acid 98% TC
- 2,4-D Sodium 95% SP
- 2,4-D Amine 866 | 720 | 480g/l SL
- 2,4-D Ethyl Hexyl Ester 96% TC
- 2,4-D Ethyl Ester 96% TC
- Chlorpyriphos 97%TC / 20%EC / 50%EC
- Thiamethoxam 96%TC / 25%WG / 75%SG
- Pretilachlor 95%TC / 50%EC / 37%EW
- Metribuzin 97%TC / 70%WS
- Hexaconazole 92%TC / 5%SC / 5%EC / 10%EC
- Metalaxyl 98%TC / 35%WS
These products are essential for various agricultural applications, including pest control and weed management.
Clients: Ambey Laboratories’ customer base includes large corporations such as:
- Aromatic Rasayan Private Limited
- JR Jindal Infraprojects Private Limited
- SC Formulator Co. Ltd
Certifications: The company’s manufacturing facility in Behror, Rajasthan, is certified with:
- ISO 9001:2015 by the Quality Research Organization
- ISO 14001:2015 by the United Accreditation Foundation
Workforce: As of October 31, 2023, Ambey Laboratories employs 220 people across various departments, ensuring efficient production and distribution of its agrochemical products.
Financial Performance (in ₹ Lakhs):
- Assets (January 31, 2024): 8,620.84
- Revenue (January 31, 2024): 10,043.69
- Profit After Tax (January 31, 2024): 607.73
- Net Worth (January 31, 2024): 3,431.34
- Reserves and Surplus (January 31, 2024): 1,562.46
- Total Borrowing (January 31, 2024): 2,005.44
Key Performance Indicators:
- Market Capitalization: ₹171.64 Cr
- Return on Equity (ROE): 20.80%
- Return on Capital Employed (ROCE): 13.14%
- Debt to Equity Ratio: 0.58
- Return on Net Worth (RoNW): 20.80%
- Price to Book Value (P/BV): 3.58
- Profit After Tax (PAT) Margin: 6.01%
Promoters:
- Archit Gupta
- Arpit Gupta
- Sarina Gupta
- Rishita Gupta
The company is gearing up for its IPO to raise funds for working capital requirements, general corporate purposes, and covering issue-related expenses. The IPO aims to further strengthen the company’s financial standing and support its ongoing growth and expansion strategies.